GEJ carcinoma

Advertisement

cGxPJobs Banner

Agilent Wins FDA Approval for PD-L1 22C3 Test

Santa Clara, USA – March 26, 2026 Agilent Technologies announced U.S. FDA approval of its PD-L1 IHC 22C3 pharmDx...

By cGxPwire Editor
March 27, 2026

Read More

Advertisement

cGxPJobs

Directory